Wealth Management Associates’s Gilead Sciences GILD Stock Holding History

Wealth Management Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$360K	Hold	2,585	–	–	0.12%	146
2025 Q4	$317K	Buy	2,585 +285	+12%	+$34.6K	0.11%	169
2025 Q3	$255K	Hold	2,300	–	–	0.09%	194
2025 Q2	$255K	Buy	+2,300	New	+$245K	0.1%	182
2021 Q3	–	Sell	-3,399	Closed	-$234K	–	197
2021 Q2	$234K	Sell	3,399 -630	-16%	-$42.1K	0.13%	178
2021 Q1	$260K	Sell	4,029 -220	-5%	-$14.2K	0.17%	146
2020 Q4	$248K	Sell	4,249 -180	-4%	-$10.9K	0.16%	146
2020 Q3	$280K	Sell	4,429 -5,576	-56%	-$387K	0.22%	117
2020 Q2	$770K	Buy	10,005 +1,494	+18%	+$114K	0.65%	38
2020 Q1	$636K	Buy	+8,511	New	+$588K	0.64%	38

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wealth Management Associates's GILD Position: Q1 2026 in Review

Wealth Management Associates held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,585 shares worth $360K. The position accounts for 0.12% of the portfolio, ranked #146.

Wealth Management Associates first reported a position in GILD in Q1 2020 and has held it in 10 quarters since. The position peaked at $770K in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Wealth Management Associates held 2,585 shares of Gilead Sciences worth $360K as of Q1 2026.
Wealth Management Associates left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.12% of Wealth Management Associates's portfolio in Q1 2026, its #146 holding.
Wealth Management Associates first reported a position in Gilead Sciences in Q1 2020 and has held it in 10 quarters since.
Wealth Management Associates's Gilead Sciences position peaked at $770K in Q2 2020.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wealth Management Associates's 13F filing for Q1 2026, filed 13 May 2026.